1. Will there be a demand from the patient group waiting for a medicine to give some persons the chance of continued life? Yes or no?
2. The agreement, will there be some bureaucrazy that make some physician to hesitate asking for the drug. Leaving their patient behind? We do not yet know.
3. What I think we can presume is that Epicept have a quite large network over the European continent through their trails and work throughout the years. Acctually. They have lifted the phone and asked their friends to order.
4. When some patients get, others not... the ball starts to roll. We will have a patient demand from the physicians.
As mentioned before, the cancer patients and their relatives, are very well informed on/by the net. They are puched against the wall, some 24 h aday.
Bottomline: There are some good reasons for the sales to be surprisingly good in this summer.
Every new patient has a 10 cycle of three weeks during 18 month.
Maybe the first week there will be ordered to some 100 patients. Or more.
Please, make a calculation of the scenario that there will only be 100 new patients each month from now on. Will we have a dilution? :-)
I see potential here, where some seeks to grab for the dillution gost. On the other hand, given the first figures from sales the leverage will be bigger IF there are some people that are afraid of the gost.
You can buy before and after. You are alone in your choise.